Gabriella Rogers

2 weeks ago | 9news.com.au | Gabriella Rogers

More men will be tested for prostate cancer as part of world-first reforms to boost early detection. There are 26,000 new cases each year in Australia and about a third are diagnosed late. A steering committee was formed to revamp 2016 testing guidelines, which were deemed too confusing, out of date and inadequate. Following consultation with leading experts and the public, the changes will be put to the National Health and Medical Health Research Council for approval.

1 month ago | 9news.com.au | Gabriella Rogers

An Australian-developed drug to ease the debilitating symptoms of dementia is being trialled in several states throughout the country. Dementia can lead to behavioural and psychological changes, affecting a majority of patients during their illness, causing them distress and putting pressure on family and caregivers.

Feb 19, 2025 | 9news.com.au | Gabriella Rogers

A new project has been launched to ensure Australians battling sarcoma don't miss out on promising new anti-cancer treatments. Sarcoma is considered a rare cancer but 2650 new cases were forecast last year. "The five year survival rate today for sarcoma patients in general is about 65%, meaning that 35 per cent of people diagnosed will go on to lose their lives," said Professor David Thomas, Director of Centre of Molecular Biology UNSW and Omico founder.

Nov 17, 2024 | 9news.com.au | Gabriella Rogers

A Sydney mum who has to use her superannuation to access a drug for ovarian cancer says not enough is being done to improve survival rates. "I feel like I have a responsibility to scream and shout loudly about it and say 'hey, this is killing women in Australia'," Vanja Wilson, 39, said. Wilson was diagnosed with advanced ovarian cancer in May after her initial symptom, a golf ball-sized lump on her abdomen, was dismissed.

Jan 31, 2024 | 9news.com.au | Gabriella Rogers

Researchers are developing a way of predicting the best treatment for patients afflicted with Australia's second-biggest cancer killer. They've used tumour samples from advanced bowel cancer patients to grow 3D models in a lab that can test different types of therapies. "Basically, there's hundreds of these little organoids growing and we can try different drugs, we can try different drugs at different doses," medical oncologist and WEHI researcher, Professor Peter Gibbs, said.